Singular Genomics(us:OMIC)

    19.55

    -1.96%

    Updated on 2024-12-22

    Open:20.18
    Close:19.55
    High:20.55
    Low:19.50
    Pre Close:19.94
    Volume:17024.00
    Amount:344697.19
    Turnover:0.68%
    Shares:2.51M
    MarketCap:49.15M

    About Singular Genomics Company

    Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.

    Company Name: Singular Genomics
    Company Address: 3010 Science Park Road
    Employees: 256
    Fiscar Year: 12-31
    IPO Date: 2021-05-27
    CIK: 1850906

    View all SEC Filings

    About

    Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.
    Address:3010 Science Park Road

    Market Movers